A carregar...

Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4

Neuroendocrine prostate cancer (NEPC) is becoming more prevalent as more potent androgen receptor (AR) pathway inhibitors are applied to patients with metastatic tumors. However, there are limited cell and xenograft models currently available, hindering the investigation of signal pathways involved...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Li, Yinan, Chen, Ruiqi, Bowden, Mary, Mo, Fan, Lin, Yen-Yi, Gleave, Martin, Collins, Colin, Dong, Xuesen
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620142/
https://ncbi.nlm.nih.gov/pubmed/28978002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19916
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!